Skip to main content

Table 2 Baseline demographic and illness characteristics (N = 532)

From: Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results

Age, ya

 

   Mean (SD)

42.3 (12.8)

   Median (min, max)

43.2 (18, 80)

Gender, n (%)

 

   Male

353 (66.4)

   Female

179 (33.6)

Ethnicity, n (%)

 

   Caucasian

321 (60.3)

   African American

126 (23.7)

   Hispanic

61 (11.5)

   Mixed race

9 (1.7)

   Other

8 (1.5)

   Asian

7 (1.3)

Duration of schizophrenia, y b

 

   Mean (SD)

17.9 (12.3)

   Median (min, max)

16.0 (0.0; 57.0)

Schizophrenia type, n (%)

 

   Paranoid

359 (67.5)

   Undifferentiated

98 (18.4)

   Disorganized

59 (11.1)

   Residual

10 (1.9)

   Catatonic

4 (0.8)

   Missing

2 (0.4)

Employment status, n (%) c

 

   Unemployed

218 (41.0)

   Disabled/long-term sick leave

134 (25.2)

   Part-time

19 (3.6)

   Full-time

14 (2.6)

   Student

5 (0.9)

   Homemaker

4 (0.8)

   Retired

3 (0.6)

   Missing

176 (33.1)

Income, n (%)

 

   <$20,000.00

239 (44.9)

   $20,000 to $34,000

15 (2.8)

   $35,000 to $49,999

4 (0.8)

   $50,000 to $74,999

1 (0.2)

   >$75,000.00

3 (0.6)

   Patient refused

3 (0.6)

   Patient unemployed

91 (17.1)

   Missing

176 (33.1)

  1. max, maximum; min, minimum; SD, standard deviation.
  2. a n = 528
  3. b n = 518
  4. cSum of percentages can be greater than 100 because patients can be in more than one group.